Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...

Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor Malignancies Neoadjuvant chemotherapy is a key component of ...

AI-driven functional precision medicine could transform cancer care by testing live tumor cells to deliver personalized, ...

Patients with myelodysplastic syndromes (MDS) exhibit diverse disease trajectories necessitating different clinical approaches ranging from watch-and-wait strategies to hematopoietic stem cell ...

Promising cancer drugs often fail in clinical development as early data lack predictive power. This interview explores data ...